Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries - Image 1

£40.65

Edward Elgar Publishing Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries

Name: Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries
Brand: Edward Elgar Publishing
Price: 40.65 GBP
Availability: InStock

Law

This is the most expensive it has ever been. Walk away.

£41 today · previous high £41 · all-time low £35

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 34 days • 34 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 34 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £35 (17 days, 50.0%)

Price range: £35 - £41

Price levels: 2 different prices over 34 days

Description

This up-to-date book examines pharmaceutical development, access to medicines, and the protection of public health in the context of two fundamental changes that the global political economy has undergone since the 1970s, the globalization of trade and production and the increased harmonization of national regulations on intellectual property rights. With authors from eleven different countries presenting case studies of national experiences in Africa, Asia and the Americas, the book analyzes national strategies to promote pharmaceutical innovation, while at the same time assuring widespread access to medicines through generic pharmaceutical production and generic pharmaceutical importation. The expert chapters focus on patents as well as an array of regulatory instruments, including pricing and drug registration policies. Presenting in-depth analysis and original empirical research, this book will strongly appeal to academics and students of intellectual property, international health, international political economy, international development and law. Contributors: T. Andia, M. Bourassa Forcier, M. Flynn, P. Gehl Sampath, S. Guennif, A. Guzman, H. Klug, G. Krikorian, N. Lalitha, J.-F. Morin, K.C. Shadlen, L. Shi, M. Watanabe

Product Specifications

Brand: Edward Elgar Publishing
Format: paperback
ASIN: 0857938797
Category: Books > Subjects > Business, Finance & Law > Law
Domain: Amazon UK
Release Date: 31 May 2013
Listed Since: 12 February 2013

Barcode

No barcode data available

Edward Elgar Publishing Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Pharmaceutical Innovation, Competition and Patent Law: A Trilateral Perspective

Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health, and Pharmaceuticals (Law, Development and Globalization)

Patent Rights in Pharmaceuticals in Developing Countries: Major Challenges for the Future

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Regional Cooperation, Intellectual Property Law and Access to Medicines: A Holistic Approach for Least Developed Countries (Routledge Research in Health Law)

Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health

Oxford University Press - Balancing Wealth and Health Book

Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World

Intellectual Property and Access to Medicines in Africa: A Regional Framework for Access (Routledge Research in Intellectual Property)

Patent Protection for Second Medical Uses (Aippi Law)

Routledge Intellectual Property and Access to Medicines in Africa

Compulsory Patent Licensing and Access to Medicines: A Silver Bullet Approach to Public Health? (Palgrave Studies in Public Health Policy Research)

Evergreening Patent Exclusivity in Pharmaceutical Products: Supplementary Protection Certificates, Orphan Drugs, Paediatric Extensions and ATMPs

Intellectual Property in the Life Sciences: A Global Guide to Rights and Their Applications, Second Edition

Routledge Pharmaceutical Industry and Public Policy in India

Intellectual Property and Health Technologies: Balancing Innovation and the Public's Health

Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)

Interpreting TRIPS: Globalisation of Intellectual Property Rights and Access to Medicines

Fundamentals of Market Access for Pharmaceuticals

Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Springer - Innovation and Marketing in Pharmaceutical Industry

PHARMACEUTICAL ECONOMICS AND POLICY 3RD EDITION: Perspectives, Promises, and Problems

Poor Quality Pharmaceuticals in Global Public Health: 5 (Trust, 5)